The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
SSRI Treatment of Borderline Personality Disorder: A Randomized, Placebo-Controlled Clinical Trial for Female Patients With Borderline Personality Disorder
Abstract
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are recommended for treatment of affect lability, impulsivity, and aggression in patients with borderline personality disorder. This recommendation is based on positive findings in at least 10 open studies and one small double-blind study of SSRIs for patients with borderline personality disorder and one study of impulsive aggressive patients with different personality disorders. A randomized, placebo-controlled SSRI study with borderline personality disorder patients, however, provided inconclusive results because of a large response to placebo. It was, therefore, decided to conduct a new randomized trial with a larger study group. METHOD: A double-blind, placebo-controlled, randomized trial using the SSRI fluvoxamine for 6 weeks followed by a blind half-crossover for 6 weeks and an open follow-up for another 12 weeks was conducted with 38 nonschizophrenic, nonbipolar female patients with borderline personality disorder. The outcome measures were the rapid mood shift, impulsivity, and aggression subscales from the Borderline Personality Disorder Severity Index. RESULTS: Fluvoxamine but not placebo produced a robust and long-lasting reduction in the scores on the subscale for rapid mood shifts. In contrast, no difference between the fluvoxamine and placebo groups was observed in the effect on the impulsivity and aggression scores. CONCLUSIONS: In this study, fluvoxamine significantly improved rapid mood shifts in female borderline patients, but not impulsivity and aggression. This latter finding may be due to gender-specific differences in impulsivity and aggression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reliability and Validity of the Borderline Personality Disorder Severity Index
Arntz, A., van den Hoorn, M., Cornelis, J., Verheul, R., van den Bosch, W. M. C., & de Bie, A. J. H. T. (2003) · Journal of Personality Disorders · doi:10.1521/pedi.17.1.45.24053 · Cited by 305
Cited by
Borderline personality disorder
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16770-6 · Cited by 1,369
Borderline personality disorder
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61422-5 · Cited by 895
Dopamine, serotonin and impulsivity
Dalley, J. W., & Roiser, J. P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.065 · Cited by 501
“Moreover, a small number of studies reported that SSRIs reduced clinical measures of impulsivity in patients with personality disorders (Soloff, 1997; Butler et al., 2010; Silva et al., 2010), though others found no such beneficial effect (Moeller et al., 2001; Rinne et al., 2002).”
Oldham, J. M. (2005) · Focus · doi:10.1176/foc.3.3.396 · Cited by 429
“robust, long-lasting reduction in rapid mood shifts only in the treatment group (70).”
BackgroundPharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
Lieb, K., Völlm, B., Rücker, G., Timmer, A., & Stoffers, J. M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.062984 · Cited by 410
Metadata
- Authors
- Rinne, T., van den Brink, W., Wouters, L., & van Dyck, R.
- Venue
- American Journal of Psychiatry
- Published
- 2002-12
- Volume
- 159
- Issue
- 12
- Pages
- 2048-2054
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2168031670
- Cited by
- 223
- References
- 1
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.